Clinical trial

M1231 in Participants With Solid Tumors

NCT04695847

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-01-13

PhasePHASE1

Study timeline

Study start (actual)2021-01-13Date precision: day

Registry last updated2023-07-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Solid Tumorsunresolved

Esophageal Cancerunresolved

Non-Small Cell Lung Cancerunresolved

Interventions

M1231DRUG

Sponsors & collaborators

EMD Serono Research & Development Institute, Inc.lead sponsor

Merck KGaA, Darmstadt, Germanycollaborator

Mapped research locations

HoustonTexas, United States1 San AntonioTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04695847 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.